US Patent Issued to ACEA Therapeutics on July 15 for "Process for manufacture of (S)-N-(3-((2-((4-((1-acetylpyrrolidin-3-yl)(methyl)amino)phenyl)amino)-5-methoxypyrimidin-4-yl)oxy)phenyl)acrylamide, and formulations thereof" (Chinese, American Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,895, issued on July 15, was assigned to ACEA Therapeutics Inc. (San Diego).

"Process for manufacture of (S)-N-(3-((2-((4-((1-acetylpyrrolidin-3-yl)(methyl)amino)phenyl)amino)-5-methoxypyrimidin-4-yl)oxy)phenyl)acrylamide, and formulations thereof" was invented by Long Mao (San Diego), Jia Liu (San Diego), Yile Chen (Hangzhou, China), Yuning Hua (Hangzhou, China), Kunhua Dong (Hangzhou, China), Liang Chen (Hangzhou, China), Bojie Weng (Hangzhou, China), Xiaopeng Mo (Hangzhou, China), Kongen Dai (Hangzhou, China), Yimei Bao (Hangzhou, China), Jian Wu (Hangzhou, China), Bin Liang (Hangzhou, China), Guanglin Zhou (Hangzhou, China) and Zhen Wang (Hangzhou, China).

According to the abs...